First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection
about
Immunosuppressive Medications.Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.Use of polyclonal/monoclonal antibody therapies in transplantation.Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains.SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
P2860
First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
First-in-human study of the sa ...... nt kidney transplant rejection
@ast
First-in-human study of the sa ...... nt kidney transplant rejection
@en
type
label
First-in-human study of the sa ...... nt kidney transplant rejection
@ast
First-in-human study of the sa ...... nt kidney transplant rejection
@en
prefLabel
First-in-human study of the sa ...... nt kidney transplant rejection
@ast
First-in-human study of the sa ...... nt kidney transplant rejection
@en
P2093
P2860
P356
P1476
First-in-human study of the sa ...... nt kidney transplant rejection
@en
P2093
A C Wiseman
J J Herrman
J P Puisis
L B Melton
P2860
P304
P356
10.1111/AJT.12698
P407
P577
2014-04-17T00:00:00Z